Inventor
JAGASIA RAVI
DE24 patents
⚠️ This page may combine multiple inventors who share the name “JAGASIA RAVI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
20 patentsUS11852627B2Dec 26, 2023
Oligonucleotides for inducing paternal UBE3A expression
HOFFMANN LA ROCHE3 citations82
US11320421B2May 3, 2022
Oligonucleotides for inducing paternal UBE3A expression
HOFFMANN LA ROCHE3 citations82
US12259380B2Mar 25, 2025
Oligonucleotides for inducing paternal UBE3A expression
HOFFMANN LA ROCHE2 citations73
US12566172B2Mar 3, 2026
Oligonucleotides for inducing paternal UBE3A expression
HOFFMANN LA ROCHE0 citations61
US12104153B2Oct 1, 2024
Antisense oligonucleotide for targeting progranulin
HOFFMANN LA ROCHE0 citations53
US12360123B2Jul 15, 2025
E3 ubiquitin ligase (UBE3A) protein targets
HOFFMANN LA ROCHE0 citations52
US9688675B2Jun 27, 2017
1,7-naphthyridine derivatives
HOFFMANN LA ROCHE0 citations52
US9586966B2Mar 7, 2017
Piperazino[1,2-a]indol-1-ones and [1,4]diazepino[1,2-a]indol-one
HOFFMANN LA ROCHE0 citations52
US9464049B2Oct 11, 2016
Indole-carboxamides
HOFFMANN LA ROCHE0 citations52
US9440962B2Sep 13, 2016
Benzisoxazoles
HOFFMANN LA ROCHE0 citations52
US9365550B2Jun 14, 2016
Benzimidazoles as CNS active agents
HOFFMANN LA ROCHE1 citations52
US9315502B2Apr 19, 2016
Imidazopyridine derivatives
HOFFMANN LA ROCHE0 citations52
US12203071B2Jan 21, 2025
Oligonucleotide agonists targeting progranulin
HOFFMANN LA ROCHE0 citations51
US12084657B2Sep 10, 2024
Oligonucleotides targeting RNA binding protein sites
HOFFMANN LA ROCHE0 citations50
US9297025B2Mar 29, 2016
Conversion of somatic cells to induced reprogrammed neural stem cells (irNSCs)
HOFFMANN LA ROCHE0 citations46
US9714239B2Jul 25, 2017
N-phenyl-lactam derivatives capable of stimulating neurogenesis and their use in the treatment of neurological disorders
HOFFMANN LA ROCHE0 citations42
US9670206B2Jun 6, 2017
Pyrido[4,3-B]pyrazine-2-carboxamides as neurogenic agents for the treatment of neurodegenerative disorders
HOFFMANN LA ROCHE0 citations42
US9657014B2May 23, 2017
Substituted 1,6-naphthyridines
HOFFMANN LA ROCHE0 citations41
US9586903B2Mar 7, 2017
Isoquinoline derivatives
HOFFMANN LA ROCHE0 citations41
US9284321B2Mar 15, 2016
Piperazino[1,2-a]indol-1-ones and [1,4]diazepino[1,2-a]indol-1-one
HOFFMANN LA ROCHE0 citations41
ROCHE INNOVATION CT COPENHAGEN AS
3 patentsUS10494633B2Dec 3, 2019
Oligonucleotides for inducing paternal UBE3A expression
ROCHE INNOVATION CT COPENHAGEN AS8 citations91
US10739332B2Aug 11, 2020
Oligonucleotides for inducing paternal UBE3A expression
ROCHE INNOVATION CT COPENHAGEN AS6 citations82
US10718753B2Jul 21, 2020
Oligonucleotides for inducing paternal UBE3A expression
ROCHE INNOVATION CT COPENHAGEN AS5 citations82